Depsipeptide for therapy of kidney cancer
View Patent ↗The present invention provides a therapeutic agent of kidney cancer, which comprises FK228 of the formula (I) or a salt thereof. FK228 or a salt thereof, which is an active ingredient in the present invention, shows a superior antitumor activity in vivo against kidney cancer.
1. A method of treating kidney cancer in a mammal in need thereof, which comprises administering an effective amount of a compound of the formula (I)
or a salt thereof to said mammal.
2. The treatment method of kidney cancer according to claim 1 , wherein the compound of the formula (I) is a compound of the formula (II)
3. The treatment method of kidney cancer according to claim 1 , wherein the mammal is a human.
4. A method of suppressing growth of a cancerous tumor of the kidney in vivo in a mammal in need thereof, which comprises administering an effective amount of a compound of the formula (I)
or a salt thereof to said mammal.
5. The method of suppressing growth of the cancerous tumor of the kidney according to claim 4 , wherein the compound of the formula (I) is a compound of the formula (II)
6. The method of claim 4 , wherein the in vivo means in a body of a human.